NYC Health + Hospitals/Woodhull Recognized as a Center of Excellence in Lung Cancer Screening

October 1, 2025 - 17:35

NYC Health + Hospitals/Woodhull has received the prestigious designation of Center of Excellence (COE) in Lung Cancer Screening from GO2 for Lung Cancer. This recognition highlights the hospital's commitment to providing high-quality lung cancer screening services and improving patient outcomes in the community.

The COE designation is awarded to healthcare facilities that meet rigorous criteria for lung cancer screening, including adherence to best practices, patient education, and comprehensive follow-up care. By achieving this status, NYC Health + Hospitals/Woodhull demonstrates its dedication to early detection and treatment of lung cancer, which is crucial for increasing survival rates.

Lung cancer remains one of the leading causes of cancer-related deaths, making effective screening programs essential. The recognition as a COE not only reflects the hospital's excellence in lung cancer screening but also reinforces its role in promoting health equity and access to critical healthcare services in underserved populations. This achievement positions Woodhull as a leader in the fight against lung cancer in New York City.